Frontage Financial Statements From 2010 to 2025
| FGHQF Stock | USD 0.15 0.00 0.00% |
Check Frontage Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Frontage Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Frontage financial statements analysis is a perfect complement when working with Frontage Holdings Valuation or Volatility modules.
Frontage |
Frontage Holdings Company Profit Margin Analysis
Frontage Holdings' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Frontage Holdings Profit Margin | 0.10 % |
Most of Frontage Holdings' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Frontage Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Frontage Holdings has a Profit Margin of 0.1033%. This is 100.92% lower than that of the Healthcare sector and 100.45% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 108.13% lower than that of the firm.
Frontage Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Frontage Holdings's current stock value. Our valuation model uses many indicators to compare Frontage Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Frontage Holdings competition to find correlations between indicators driving Frontage Holdings's intrinsic value. More Info.Frontage Holdings is rated # 4 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Frontage Holdings is roughly 1.65 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Frontage Holdings' earnings, one of the primary drivers of an investment's value.About Frontage Holdings Financial Statements
Frontage Holdings stakeholders use historical fundamental indicators, such as Frontage Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Frontage Holdings investors may analyze each financial statement separately, they are all interrelated. For example, changes in Frontage Holdings' assets and liabilities are reflected in the revenues and expenses on Frontage Holdings' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Frontage Holdings. Please read more on our technical analysis and fundamental analysis pages.
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited. Frontage Hldgs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1505 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Frontage Pink Sheet
Frontage Holdings financial ratios help investors to determine whether Frontage Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Frontage with respect to the benefits of owning Frontage Holdings security.